Bluebird prices gene therapy at 1.58 million euros over 5 years


Bluebird bio Inc on Friday set a price for its gene therapy, Zynteglo, at 1.58 million euros ($1.78 million) over five years, after winning conditional approval ... Read more

Bron: Reuters: Health News
Tags: Europa
Geplaatst: 14 Jun 2019 - 20:56